Results 221 to 230 of about 2,044,342 (365)
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley +1 more source
Application of CRISPR/Cas gene editing for infectious disease control in poultry. [PDF]
Gallala M.
europepmc +1 more source
Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations
Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan+4 more
wiley +1 more source
Enhanced Environmental Disinfection [PDF]
Anderson, Deverick J, MD, MPH, FIDSA, FSHEA
core +1 more source
Monitoring Macrophage Polarization in Infectious Disease, Lesson From SARS-CoV-2 Infection. [PDF]
Mezouar S, Mege JL.
europepmc +2 more sources
Towards a 'people and nature' paradigm for biodiversity and infectious disease. [PDF]
Gibb R, Redding DW, Friant S, Jones KE.
europepmc +1 more source
The temporary transition of macrophages from a pro‐inflammatory phenotype of macrophages (M1) to an anti‐inflammatory phenotype of macrophages (M2) is crucial for tissue repair and regeneration processes. Bacterial outer membrane vesicles (OMVs) are utilized as a “trojan horse” for specific M1 macrophage‐targeting and anti‐inflammatory drug delivery ...
Donglin Cai+9 more
wiley +1 more source